1.86
1.86 (0%)
As of Feb 14, 2025
Brainstorm Cell Therapeutics Inc. [BCLI]
Source:
Company Overview
Brainstorm Cell Therapeutics Inc is a leading biotechnology company engaged in the development of best-in-class autologous cellular therapies derived from a patient’s own bone marrow cells for the treatment of neurodegenerative diseases.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 201-488-0460 |
| Industry | manufacturing |
| CEO | Chaim Lebovits |
| Website | brainstorm-cell.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $0 |
| Net Income | $0 |
| Net Cash | $-3.3 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | |
| Profit as % of Stockholder Equity |
Management Effectiveness
| Return on Equity | |
| Return on Assets | |
| Turnover Ratio | |
| EBITA | $0 |
Balance Sheet and Cash Flow Measures
| Total Assets | $2 |
| Total Liabilities | $8.1 |
| Operating Cash Flow | $-3.3 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0 |
